MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time.The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.About Hologic, Inc.Hologic, Inc. is an innovative medical tech ...

FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 _________________________________________________ ...

Hologic, Inc. (NASDAQ:HOLX) Q4 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Conference Call Participants Puneet Souda - Leerink Partners Jack Meehan - Nephron Research Derik De Bruin - Bank of America Patrick Donnelly - Citi Timothy Daley - Wells Fargo Anthony Petrone - Mizuho Group Casey Woodring - JPMorgan Navann Ty - BNP Paribas Exane Michael Matson - Needh ...

Hologic, Inc. (NASDAQ:HOLX) Q3 2023 Earnings Conference Call July 31, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Michael Matson - Needham & Company Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Timothy Daley - Wells Fargo Tejas Savant - Morgan Stanley Puneet Souda - Leerink Partners Anthony Pet ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGIC ...

Hologic, Inc. (NASDAQ:HOLX) Q2 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Tim Daley - Wells Fargo Casey Woodring - JPMorgan Anthony Petrone - Mizuho Group Elizabeth Garcia - UBS Andrew Cooper - Raymond James Jack Meehan - Nephron Research Puneet Souda - SVB Securities Jack Meehan - Nephron Research Max Masucci - Cowen & Company Tejas Sa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGI ...

Hologic, Inc. (NASDAQ:HOLX) Q1 2023 Earnings Conference Call February 1, 2023 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Max Masucci - Cowen & Company Puneet Souda - SVB Securities Vijay Kumar - Evercore ISI Tim Daley - Wells Fargo Tejas Savant - Morgan Stanley Derik de Bruin - Bank of America Dustin Scaringe - William Blair Navann Ty - BNP Pariba ...

Millions • 14.7% constant currency organic Strong Balance Sheet for Future Capital Deployment Opportunities • No near-term debt maturities, no balance outstanding on revolver 25 *Net debt is total debt minus cash in $ billions; leverage ratio is principal debt minus cash to TTM adjusted EBITDA Introduction Results Driven 26 • Purpose Driven, Results Driven ...with Leadership Across the Continuum of Care SUP 23 24 • Stability in NovaSure Non-COVID Panther Utilization Metrics • Panther non-COVID utilization g ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HO ...